miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w

Oncology Reports

Volumn 27, Issue 1, 2012, Pages 250-257

  Yang, Xiaoyan ^a   Yin, Jie ^a   Yu, Jia ^a   Xiang, Qiong ^a   Liu, Yunmei ^a   Tang, Shensong ^a   Liao, Duanfang ^a   Zhu, Bingyang ^a   Zu, Xuyu ^a   Tang, Huifang ^a   Lei, Xiaoyong ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

5 Fluorouracil; Bcl w; Hepatocellular carcinoma; miR 195

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; FLUOROURACIL; LUCIFERASE; MICRORNA; MICRORNA 195; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BCL XL; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; BCL W GENE; BCL XL GENE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REAL TIME POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUOROURACIL; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84855293549     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1472     Document Type: Article

References (30)

1. Seeff LB and Hoofnagle JH: Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity. Oncogene 25: 3771-3777, 2006. (Pubitemid 43980472)
2. Di Bisceglie AM: Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl 1): S104-S107, 2004.
3. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
4. Takehara T, Liu X, Fujimoto J, Friedman SL and Takahashi H: Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34: 55-61, 2001. (Pubitemid 32591483)
5. Thorgeirsson SS, Lee JS and Grisham JW: Functional genomics of hepatocellular carcinoma. Hepatology 43 (2 Suppl 1): S145-S150, 2006.
6. Fabregat I, Roncero C and Fernandez M: Survival and apoptosis: a dysregulated balance in liver cancer. Liver Int 27: 155-162, 2007. (Pubitemid 46680718)
7. Lee RC and Ambros V: An extensive class of small RNAs in Caenorhabditis elegans. Science 294: 862-864, 2001. (Pubitemid 33032105)
8. Skaftnesmo KO, Prestegarden L, Micklem DR and Lorens JB: MicroRNAs in tumorigenesis. Curr Pharm Biotechnol 8: 320-325, 2007. (Pubitemid 350268190)
9. Hobert O: Gene regulation by transcription factors and microRNAs. Science 319: 1785-1786, 2008.
10. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121, 2009.
11. Liu L, Chen L, Xu Y, Li R and Du X: microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem Biophys Res Commun 400: 236-240, 2010.
12. Gibson L, Holmgreen SP, Huang DC, Bernard O, Copeland NG, Jenkins NA, Sutherland GR, Baker E, Adams JM and Cory S: bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene 13: 665-675, 1996. (Pubitemid 26312893)
13. Kitamura S, Kondo S, Shinomura Y, Kanayama S, Miyazaki Y, Kiyohara T, Hiraoka S and Matsuzawa Y: Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers. Br J Cancer 83: 668-673, 2000. (Pubitemid 30636311)
14. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD and McCaughan GW: Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 160: 641-654, 2002. (Pubitemid 34160342)
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005. (Pubitemid 40839735)
16. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005. (Pubitemid 40617277)
17. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007. (Pubitemid 46991392)
18. Reed JC: Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 7: 541-546, 1995.
19. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J and Fan D: miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 123: 372-379, 2008. (Pubitemid 351842022)
20. Wu W, Sun M, Zou GM and Chen J: MicroRNA and cancer: Current status and prospective. Int J Cancer 120: 953-960, 2007. (Pubitemid 46214293)
21. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S and Majumder S: MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283: 29897-29903, 2008.
22. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST and Ghoshal K: Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem 283: 33394-33405, 2008.
23. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R and Kroemer G: Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 57: 62-67, 1997. (Pubitemid 27020331)
24. Tong X, Lin S, Fujii M and Hou DX: Molecular mechanisms of echinocystic acid-induced apoptosis in HepG2 cells. Biochem Biophys Res Commun 321: 539-546, 2004. (Pubitemid 39118377)
25. Luo D, Cheng SC and Xie Y: Expression of Bcl-2 family proteins during chemotherapeutic agents-induced apoptosis in the hepatoblastoma HepG2 cell line. Br J Biomed Sci 56: 114-122, 1999. (Pubitemid 29335605)
26. Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187, 2006. (Pubitemid 44527848)
27. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG and Sidhu SB: miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 15: 7684-7692, 2009.
28. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505, 2010.
29. Zhang H, Su SB, Zhou QM and Lu YY: Differential expression profiles of microRNAs between breast cancer cells and mammary epithelial cells. Ai Zheng 28: 493-499, 2009.
30. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcao RP and Zago MA: miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 40: 1435-1440, 2007. (Pubitemid 350302855)